Blood Glucose Test Strips Market By Distribution Type, By Diabetes Type, By End-use, and By Region Forecast to 2030

Market Synopsis:

The global market for blood glucose test strips was worth USD 12.35 billion in 2021 and is expected to grow at a CAGR of 6.1% during the forecast period. The market growth is being driven by factors such as the increasing prevalence of type-2 diabetes, the rising demand for home blood glucose monitoring systems, and the shift from venipuncture blood sugar tests to easy-to-use test kits. Additionally, the increasing awareness about the benefits of early detection of diseases and preventive measures, as well as the rising prevalence of diabetes-related diseases such as Cardiovascular Disease (CVD), neuropathy, and nephropathy, are also contributing to the adoption of blood glucose test strips among diabetic patients. The use of Self-Monitoring Blood Glucose (SMBG) devices like test strips, helps in the prevention of diabetic hypoglycemia and other potential medical conditions. Test strips are the preferred choice among SMBG devices as they are minimally invasive, easy to use and do not require surgical procedure for checking blood glucose level. The increasing prevalence of diabetes worldwide and its associated direct medical costs, which according to the 2016 Global Report on Diabetes by the World Health Organization (WHO) is projected to be USD 1.7 trillion from 2011 to 2030 due to direct and indirect costs of diabetes, are also driving the demand for blood glucose test strips.

Market Dynamics:

Driver: Increasing global prevalence of type-2 diabetes is driving the blood glucose test strips market revenue growth

Various factors such as weight gain and obesity, family history, overconsumption of food, limited physical activity and sedentary lifestyle, and pregnancy can cause diabetes. Long-term diabetes can result in several diseases, including CVDs, neurological problems, and kidney damage. The prevalence of diabetes and associated diseases has been increasing steadily in recent years. According to the IDF Atlas, the global number of diabetic patients has increased from 366 million in 2011 to 536 million in 2021. CVDs account for approximately 17.9 million deaths annually, and the mortality rate can be reduced by periodic monitoring of blood sugar levels to treat diabetes. Blood glucose test kits, consisting of a glucometer and analytical test strips, enable patients to conveniently check blood sugar levels. Hypoglycemia is generally associated with geriatric patients being treated for multiple diseases and can be controlled by regular blood glucose monitoring.

Nephropathy, which is the deterioration in functioning of kidneys, is frequently attributed to diabetes and can be treated by controlling diabetes and high blood pressure. The rising incidence of kidney failure globally is driving the adoption of blood glucose test strips, which is expected to continue to support market revenue growth. Diabetic Ketoacidosis (DKA), which results from the metabolism of fat due to a deficiency of glucose, results in the accumulation of ketones in the blood and decreases pH. Unless treated, DKA is a life-threatening disease. SMBG devices, particularly test strips, enable patients with DKA to keep their blood glucose levels in check and avoid potential severity.

Restraint: Finger-prick

requirement for glucose testing on strips is causing reluctance among some patients
Glucometer test kits typically involve a fingerprick using a lancet to draw blood for the test strip. However, this procedure can cause pain and some patients may be reluctant to use such tests. Moreover, the strips have short expiry periods, cannot be reused, and are affected by changes in temperature, sample quality, and humidity. Additionally, glucometer tests may not provide accurate results for diabetic patients with hypotension, anemia, and altered hematocrit. While the cost of the device is a one-time investment, the high cost of test strips can be a significant burden for patients. These factors, among others, may hinder the growth of market revenue to some extent.

Key Takeaways:

Distribution Type Outlook: The global blood glucose test strips market has been categorized into two types: Over-The-Counter (OTC) and online. The OTC segment is predicted to account for a considerable share of revenue during the forecast period. The high availability of SMBG devices through retail stores and pharmacies, along with product quality assurance, are the major drivers behind the segment's revenue growth. Low and Middle-Income Countries (LMICs) depend mostly on public and private retail pharmacy channels for purchasing glucometer kits, and some patients who require assistance visit nearby pharmacies. This dependence is boosting revenue growth of the OTC segment.

The online segment is expected to show rapid revenue growth during the forecast period. This is because of the ease of placing orders and lower prices available on e-commerce platforms. These platforms have made access to medical devices and test kits easy and convenient, particularly for the elderly and those with mobility issues. The wider range of products available on online platforms and lower costs compared to retail channels are making online purchasing increasingly popular and driving market revenue growth.

End-Use Outlook:

The global market for blood glucose test strips is categorized by end-use into hospitals, diagnostic centers, nursing homes and polyclinics, and pharmacies and retail outlets. Over the forecast period, the hospitals segment is expected to contribute significantly to the revenue share. The use of glucose meter kits in hospitals helps to accelerate the operational time as these tests provide quick results compared to conventional laboratory tests. SMBG devices are minimally invasive and less painful for patients, making it a convenient method, especially for patients who prefer not to use venipuncture methods through syringes or those who suffer from hemophobia. Furthermore, some patients prefer to visit hospitals for blood glucose testing by trained medical practitioners, and this preference is driving the growth of this segment.

The revenue generated by the pharmacies and retail outlets segment is projected to grow rapidly from 2022 to 2030. Sales of self-monitoring blood glucose devices are high through pharmacies, retail outlets, and e-commerce platforms due to the ease of use of such devices and rising preference among patients, particularly after the COVID-19 outbreak, for home-based diagnostic tests and monitoring. The American Diabetes Association (ADA) recommends that patients with type-1 diabetes should check their blood glucose levels multiple times each day. The bulk purchase of test strips makes this process more affordable and convenient, and this is expected to continue supporting the revenue growth of this segment.

Regional Outlook:

During the forecast period, the Asia Pacific blood glucose test strips market is predicted to account for the largest revenue share in the global market. This growth is primarily due to the rapid increase in diabetes prevalence in the region, with India projected to have 92.9 million cases by 2030. The North America blood glucose test strips market is expected to register a steady revenue CAGR due to the robust presence of key manufacturers in the region, with an increasing number of health-conscious individuals opting for blood glucose tests and level monitoring. The Europe blood glucose test strips market is anticipated to have a relatively large revenue share during the forecast period, driven by high prevalence of diabetes due to obesity and overweight, with 60 million individuals having the disease. Moreover, increasing awareness about diabetes and need for treatment are key factors driving market revenue growth over the forecast period.

Competitive Landscape:

The global blood glucose test strips market has a moderately fragmented competitive landscape with numerous key players operating on global and regional levels. These key players are focused on developing and conducting trials for medical devices, test kits, and engaging in strategic partnerships and agreements to expand their product portfolios and gain a strong foothold in the global market. Notable companies in the global market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Agamatrix, Ascensia Diabetes Care Holdings AG, LifeScan, Inc., ARKRAY, Inc., Medtronic plc, Bionime Corporation, Care Touch LLC, and DarioHealth Corporation.

On April 4th, 2022, Ascensia Diabetes Care announced the launch of the Eversense E3 Continuous Glucose Monitoring (CGM) System in the U.S., which will be available to patients. Developed by Senseonics Holdings, Inc., this product has been approved by the Food and Drug Administration (FDA) for a usage period of six months, making it the longest commercially available CGM sensor in the U.S. Ascensia has also created the Eversense Payment Assistance and Simple Savings (PASS) Program, aimed at making CGM systems more accessible and affordable to patients with irregular blood glucose levels.

Abbott Laboratories announced on April 4th, 2022, that the Aveir single-chamber leadless pacemaker had been approved by the U.S. Food and Drug Administration (FDA). The product is designed to treat patients with slow cardiac rhythms and is implanted in the right ventricle of the patient without the need for a chest incision. The FDA approval is expected to drive advances in the treatment of cardiac patients.

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2022-2030

Chapter 3. Indicative Metrics

Chapter 4. Blood Glucose Test Strips Market Segmentation & Impact Analysis
4.1. Blood Glucose Test Strips Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.2.1. Increasing global prevalence of type-2 diabetes
4.2.2.2. Increasing demand for home blood glucose monitoring systems by patients of diabetes and hypoglycemia
4.2.2.3. Steady shift of blood sugar tests from diagnostic laboratories and hospitals to easy-to-use test kits
4.2.2.4. Rise of diabetes-related diseases such as Cardiovascular Disease (CVD), neuropathy, and nephropathy
4.2.3. Market restraints analysis
4.2.3.1. Lack of patient compliance due to pain while using blood glucose test strips
4.2.3.2. High cost and lack of technical knowledge to operate digital glucose meters
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. COVID-19 Impact Analysis
4.11. Global Recession Influence

Chapter 5. Blood Glucose Test Strips Market by Distribution Type Insights & Trends
5.1. Distribution Type Dynamics & Market Share, 2022 & 2030
5.2. Over the Counter
5.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
5.3. Online
5.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)

Chapter 6. Blood Glucose Test Strips Market by Diabetes Type Insights & Trends
6.1. Diabetes Type Dynamics & Market Share, 2022 & 2030
6.2. Type-1 Diabetes
6.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.3. Type-2 Diabetes
6.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.4. Prediabetes
6.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.5. Gestational Diabetes
6.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)

Chapter 7. Blood Glucose Test Strips Market by End-use Insights & Trends
7.1. End-use Dynamics & Market Share, 2022 & 2030
7.2. Hospitals
7.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.3. Diagnostic Centres
7.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.4. Nursing Homes and Polyclinics
7.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.5. Pharmacies and Retail Outlets
7.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)

Chapter 8. Blood Glucose Test Strips Market Regional Outlook
8.1. Blood glucose test strips Market Share by Region, 2022 & 2030
8.2. North America
8.2.1. North America Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.2.2. North America Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.2.3. North America Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.2.4. North America Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.2.5. U.S.
8.2.5.1. U.S. Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.2.5.2. U.S. Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.2.5.3. U.S. Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.2.5.4. U.S. Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.2.6. Canada
8.2.6.1. Canada Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.2.6.2. Canada Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.2.6.3. Canada Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.2.6.4. Canada Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.2.7. Mexico
8.2.7.1. Mexico Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.2.7.2. Mexico Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.2.7.3. Mexico Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.2.7.4. Mexico Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3. Europe
8.3.1. Europe Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.2. Europe Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.3. Europe Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.4. Europe Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.5. Germany
8.3.5.1. Germany Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.5.2. Germany Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.5.3. Germany Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.5.4. Germany Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.6. U.K.
8.3.6.1. U.K. Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.6.2. U.K. Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.6.3. U.K. Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.6.4. U.K. Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.7. France
8.3.7.1. France Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.7.2. France Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.7.3. France Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.7.4. France Blood glucose test strips Market estimates and forecast by End-use type, 2019 - 2030, (USD Billion)
8.3.8. Italy
8.3.8.1. Italy Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.8.2. Italy Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.8.3. Italy Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.8.4. Italy Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.9. Spain
8.3.9.1. Spain Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.9.2. Spain Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.9.3. Spain Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.9.4. Spain Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.10. Sweden
8.3.10.1. Sweden Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.10.2. Sweden Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.10.3. Sweden Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.10.4. Sweden Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.11. BENELUX
8.3.11.1. BENELUX Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.11.2. BENELUX Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.11.3. BENELUX Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.11.4. BENELUX Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.3.12. Rest of Europe
8.3.12.1. Rest of Europe Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.3.12.2. Rest of Europe Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.3.12.3. Rest of Europe Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.3.12.4. Rest of Europe Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4. Asia Pacific
8.4.1. Asia-Pacific Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.2. Asia-Pacific Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.3. Asia-Pacific Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.4. Asia-Pacific Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4.5. China
8.4.5.1. China Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.5.2. China Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.5.3. China Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.5.4. China Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4.6. India
8.4.6.1. India Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.6.2. India Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.6.3. India Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.6.4. India Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4.7. Japan
8.4.7.1. Japan Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.7.2. Japan Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.7.3. Japan Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.7.4. Japan Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4.8. South Korea
8.4.8.1. South Korea Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.8.2. South Korea Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.8.3. South Korea Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.8.4. South Korea Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.4.9. Rest of APAC
8.4.9.1. Rest of APAC Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.4.9.2. Rest of APAC Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.4.9.3. Rest of APAC Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.4.9.4. Rest of APAC Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.5. Latin America
8.5.1. Latin America Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.5.2. Latin America Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.5.3. Latin America Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.5.4. Latin America Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.5.5. Brazil
8.5.5.1. Brazil Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.5.5.2. Brazil Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.5.5.3. Brazil Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.5.5.4. Brazil Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.5.6. Rest of LATAM
8.5.6.1. Rest of LATAM Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.5.6.2. Rest of LATAM Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.5.6.3. Rest of LATAM Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.5.6.4. Rest of LATAM Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6. Middle East & Africa
8.6.1. Middle East & Africa Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.2. Middle East & Africa Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.6.3. Middle East & Africa Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.4. Middle East & Africa Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6.5. Saudi Arabia
8.6.5.1. Saudi Arabia Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.5.2. Saudi Arabia Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.6.5.3. Saudi Arabia Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.5.4. Saudi Arabia Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6.6. UAE
8.6.6.1. UAE Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.6.2. UAE Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.6.6.3. UAE Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.6.4. UAE Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6.7. South Africa
8.6.7.1. South Africa Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.7.2. South Africa Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.6.7.3. South Africa Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.7.4. South Africa Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6.8. Israel
8.6.8.1. Israel Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.8.2. Israel Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion)
8.6.8.3. Israel Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.8.4. Israel Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)
8.6.9. Rest of MEA
8.6.9.1. Rest of MEA Blood glucose test strips Market estimates and forecast, 2019 - 2030, (USD Billion)
8.6.9.2. Rest of MEA Blood glucose test strips Market estimates and forecast by Distribution Type, 2019 - 2030, (USD Billion
8.6.9.3. Rest of MEA Blood glucose test strips Market estimates and forecast by Diabetes Type, 2019 - 2030, (USD Billion)
8.6.9.4. Rest of MEA Blood glucose test strips Market estimates and forecast by End-use, 2019 - 2030, (USD Billion)

Chapter 9. Competitive Landscape
9.1. Market Revenue Share By Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Market positioning
9.5. Strategy Benchmarking
9.6. Vendor Landscape

Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Application Insights
10.1.4. Strategic Initiatives
10.2. F. Hoffmann-La Roche Ltd.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Application Insights
10.2.4. Strategic Initiatives
10.3. Agamatrix
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Application Insights
10.3.4. Strategic Initiatives
10.4. Ascensia Diabetes Care Holdings AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Application Insights
10.4.4. Strategic Initiatives
10.5. LifeScan, Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Application Insights
10.5.4. Strategic Initiatives
10.6. ARKRAY, Inc
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Application Insights
10.6.4. Strategic Initiatives
10.7. Medtronic plc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Application Insights
10.7.4. Strategic Initiatives
10.8. Bionime Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Application Insights
10.8.4. Strategic Initiatives
10.9. Care Touch LLC
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Application Insights
10.9.4. Strategic Initiatives
10.10. DarioHealth Corporation
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Application Insights
10.10.4. Strategic Initiatives